Entity Public Float of Vistagen Therapeutics, Inc. from 28 Jun 2012 to 30 Sep 2024

Taxonomy & unit
dei: USD
Description
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary
Vistagen Therapeutics, Inc. quarterly Entity Public Float in USD history and change rate from 28 Jun 2012 to 30 Sep 2024.
  • Vistagen Therapeutics, Inc. Entity Public Float for the quarter ending 30 Sep 2024 was $81,200,000, a 30% increase year-over-year.
Source SEC data
View on sec.gov
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Change (%)

Vistagen Therapeutics, Inc. Quarterly Entity Public Float (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $81,200,000 +$18,500,000 +30% 30 Sep 2024 10-K 17 Jun 2025 2025 FY
Q3 2023 $62,700,000 +$31,497,338 +101% 30 Sep 2023 10-K 11 Jun 2024 2024 FY
Q3 2022 $31,202,662 -$505,607,227 -94% 30 Sep 2022 10-K 28 Jun 2023 2023 FY
Q3 2021 $536,809,889 +$485,444,144 +945% 30 Sep 2021 10-K 23 Jun 2022 2022 FY
Q3 2020 $51,365,745 +$6,013,387 +13% 30 Sep 2020 10-K 29 Jun 2021 2021 FY
Q3 2019 $45,352,358 +$4,240,920 +10% 30 Sep 2019 10-K 29 Jun 2020 2020 FY
Q3 2018 $41,111,438 +$22,806,414 +125% 30 Sep 2018 10-K 25 Jun 2019 2019 FY
Q3 2017 $18,305,024 -$15,728,473 -46% 30 Sep 2017 10-K 26 Jun 2018 2018 FY
Q3 2016 $34,033,497 +$20,342,087 +149% 30 Sep 2016 10-K 29 Jun 2017 2017 FY
Q3 2015 $13,691,410 +$3,606,916 +36% 30 Sep 2015 10-K 24 Jun 2016 2016 FY
Q3 2014 $10,084,494 +$428,894 +4.4% 30 Sep 2014 10-K 29 Jun 2015 2015 FY
Q2 2014 $9,655,600 +$1,338,186 +16% 19 Jun 2014 10-K 25 Jun 2014 2014 FY
Q4 2013 $9,655,600 +$1,338,186 +16% 10 Feb 2014 10-Q 14 Feb 2014 2013 Q3
Q3 2013 $9,655,600 +$1,338,186 +16% 12 Nov 2013 10-Q 14 Nov 2013 2013 Q2
Q2 2013 $8,317,414 -$13,893,312 -63% 12 Jul 2013 10-K 18 Jul 2013 2012 FY
Q4 2012 $8,317,414 12 Feb 2013 10-Q 14 Feb 2013 2012 Q3
Q3 2012 $8,317,414 12 Nov 2012 10-Q 14 Nov 2012 2012 Q2
Q2 2012 $22,210,726 28 Jun 2012 10-K 02 Jul 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.